Addiction

Ibogaine By David Dardashti Introduces New Algorithm for Depression Treatment

A Revolutionary Advancement in Depression Treatments Ibogaine by David Dardashti A new algorithm to help combat depression MIAMI, April 21,…

2 years ago

Mobilize Recovery Cross-Country Bus Tour Galvanizes Community, Prevents Overdoses

Fifteen cities to host events in partnership with iHeartMedia, Meta, SAMHSA, Inseparable, and dozens of community partners coinciding with nationwide…

2 years ago

Revolutionizing Pain Management in Urgent Care Centers

United Pain Urgent Care is Pioneering Non-Opioid Solutions for Acute Pain RENO, NV / ACCESSWIRE / April 17, 2023 /…

2 years ago

BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates

Company Announces 11th Recent System Installed in Israel, with More Expected this YearBURLINGTON, Mass. and JERUSALEM, April 17, 2024 (GLOBE…

2 years ago

Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders

Tel Aviv, Israel / Vancouver, Canada, April 17, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind”…

2 years ago

atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology

BPL-003 is Beckley Psytech’s novel patent-protected benzoate salt formulation of 5-MeO-DMT that is administered intranasally.BPL-003 was shown to be safe…

2 years ago

Awakn Life Sciences Announces Closing of Tranche of Private Placement

Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…

2 years ago

Chromocell Issues Letter to Stockholders from Chief Executive Officer

FREEHOLD, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer…

2 years ago

Clearmind Medicine CEO Issues Letter to Shareholders

Vancouver, Canada, April 09, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq:CMND), (FSE: CWY0) (“Clearmind” or the “company”), a clinical-stage…

2 years ago